JP2019524149A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019524149A5 JP2019524149A5 JP2019510339A JP2019510339A JP2019524149A5 JP 2019524149 A5 JP2019524149 A5 JP 2019524149A5 JP 2019510339 A JP2019510339 A JP 2019510339A JP 2019510339 A JP2019510339 A JP 2019510339A JP 2019524149 A5 JP2019524149 A5 JP 2019524149A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- crispr
- cas9 system
- snp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091033409 CRISPR Proteins 0.000 claims 125
- 238000010354 CRISPR gene editing Methods 0.000 claims 56
- 239000002773 nucleotide Substances 0.000 claims 32
- 125000003729 nucleotide group Chemical group 0.000 claims 32
- 230000035772 mutation Effects 0.000 claims 28
- 206010011005 corneal dystrophy Diseases 0.000 claims 26
- 208000003923 Hereditary Corneal Dystrophies Diseases 0.000 claims 20
- 108091027544 Subgenomic mRNA Proteins 0.000 claims 18
- 101710163270 Nuclease Proteins 0.000 claims 17
- 206010064571 Gene mutation Diseases 0.000 claims 10
- 210000000130 stem cell Anatomy 0.000 claims 10
- 108700006666 betaIG-H3 Proteins 0.000 claims 9
- 108020004414 DNA Proteins 0.000 claims 6
- 201000004889 corneal granular dystrophy Diseases 0.000 claims 6
- 208000014706 granular corneal dystrophy Diseases 0.000 claims 6
- 230000001717 pathogenic effect Effects 0.000 claims 6
- 102000053602 DNA Human genes 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 102200040436 rs121909211 Human genes 0.000 claims 5
- 241000191940 Staphylococcus Species 0.000 claims 4
- 241000194017 Streptococcus Species 0.000 claims 4
- 101150040304 TGFBI gene Proteins 0.000 claims 4
- 102220601842 Transforming growth factor-beta-induced protein ig-h3_N622K_mutation Human genes 0.000 claims 4
- 210000004087 cornea Anatomy 0.000 claims 4
- 102200040405 rs121909211 Human genes 0.000 claims 4
- 102200040244 rs121909215 Human genes 0.000 claims 4
- 102200040225 rs121909217 Human genes 0.000 claims 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 3
- 102220600069 Transforming growth factor-beta-induced protein ig-h3_L527R_mutation Human genes 0.000 claims 3
- 230000000295 complement effect Effects 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 102200040258 rs121909208 Human genes 0.000 claims 3
- 102200040253 rs121909209 Human genes 0.000 claims 3
- 102200040434 rs121909210 Human genes 0.000 claims 3
- 201000004173 Epithelial basement membrane dystrophy Diseases 0.000 claims 2
- 102100028953 Gelsolin Human genes 0.000 claims 2
- 101001059150 Homo sapiens Gelsolin Proteins 0.000 claims 2
- 101000975472 Homo sapiens Keratin, type I cytoskeletal 12 Proteins 0.000 claims 2
- 101001056469 Homo sapiens Keratin, type II cytoskeletal 3 Proteins 0.000 claims 2
- 101000608653 Homo sapiens UbiA prenyltransferase domain-containing protein 1 Proteins 0.000 claims 2
- 102100023967 Keratin, type I cytoskeletal 12 Human genes 0.000 claims 2
- 102100025759 Keratin, type II cytoskeletal 3 Human genes 0.000 claims 2
- 102220620636 Lysosomal acid glucosylceramidase_L509P_mutation Human genes 0.000 claims 2
- 208000009869 Neu-Laxova syndrome Diseases 0.000 claims 2
- 108010077850 Nuclear Localization Signals Proteins 0.000 claims 2
- 102220552750 Proprotein convertase subtilisin/kexin type 9_F515L_mutation Human genes 0.000 claims 2
- 102220569565 Ribonuclease P protein subunit p14_L558P_mutation Human genes 0.000 claims 2
- 102220600031 Transforming growth factor-beta-induced protein ig-h3_A546T_mutation Human genes 0.000 claims 2
- 102220601844 Transforming growth factor-beta-induced protein ig-h3_G594V_mutation Human genes 0.000 claims 2
- 102220601850 Transforming growth factor-beta-induced protein ig-h3_H572R_mutation Human genes 0.000 claims 2
- 102220601839 Transforming growth factor-beta-induced protein ig-h3_H626P_mutation Human genes 0.000 claims 2
- 102220601833 Transforming growth factor-beta-induced protein ig-h3_H626R_mutation Human genes 0.000 claims 2
- 102220600360 Transforming growth factor-beta-induced protein ig-h3_L518P_mutation Human genes 0.000 claims 2
- 102220600362 Transforming growth factor-beta-induced protein ig-h3_L518R_mutation Human genes 0.000 claims 2
- 102220601849 Transforming growth factor-beta-induced protein ig-h3_L569R_mutation Human genes 0.000 claims 2
- 102220601846 Transforming growth factor-beta-induced protein ig-h3_N622H_mutation Human genes 0.000 claims 2
- 102220600049 Transforming growth factor-beta-induced protein ig-h3_T538R_mutation Human genes 0.000 claims 2
- 102220600365 Transforming growth factor-beta-induced protein ig-h3_V505D_mutation Human genes 0.000 claims 2
- 102220600051 Transforming growth factor-beta-induced protein ig-h3_V539D_mutation Human genes 0.000 claims 2
- 102220601789 Transforming growth factor-beta-induced protein ig-h3_V631D_mutation Human genes 0.000 claims 2
- 102100039547 UbiA prenyltransferase domain-containing protein 1 Human genes 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 102000054765 polymorphisms of proteins Human genes 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 230000001105 regulatory effect Effects 0.000 claims 2
- 102200040404 rs121909210 Human genes 0.000 claims 2
- 102200040401 rs121909212 Human genes 0.000 claims 2
- 102200040397 rs121909214 Human genes 0.000 claims 2
- 102200040403 rs121909216 Human genes 0.000 claims 2
- 102200137143 rs121918254 Human genes 0.000 claims 2
- 102200040392 rs267607109 Human genes 0.000 claims 2
- 102200040393 rs267607110 Human genes 0.000 claims 2
- 102220055023 rs369100046 Human genes 0.000 claims 2
- 102200055968 rs374603772 Human genes 0.000 claims 2
- 102200004603 rs58343600 Human genes 0.000 claims 2
- 102220218946 rs762018538 Human genes 0.000 claims 2
- 102220240577 rs764854618 Human genes 0.000 claims 2
- 102220323268 rs772652517 Human genes 0.000 claims 2
- 102220392615 rs774013935 Human genes 0.000 claims 2
- 102200040399 rs777288957 Human genes 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 102220531909 Gelsolin_D214Y_mutation Human genes 0.000 claims 1
- 108020005004 Guide RNA Proteins 0.000 claims 1
- 101000894525 Homo sapiens Transforming growth factor-beta-induced protein ig-h3 Proteins 0.000 claims 1
- 102220637260 Keratin, type I cytoskeletal 12_L132V_mutation Human genes 0.000 claims 1
- 102000008300 Mutant Proteins Human genes 0.000 claims 1
- 108010021466 Mutant Proteins Proteins 0.000 claims 1
- 102100021398 Transforming growth factor-beta-induced protein ig-h3 Human genes 0.000 claims 1
- 102220600114 Transforming growth factor-beta-induced protein ig-h3_D123H_mutation Human genes 0.000 claims 1
- 102220600131 Transforming growth factor-beta-induced protein ig-h3_V113I_mutation Human genes 0.000 claims 1
- 102220540617 UbiA prenyltransferase domain-containing protein 1_A97T_mutation Human genes 0.000 claims 1
- 102220540625 UbiA prenyltransferase domain-containing protein 1_D112N_mutation Human genes 0.000 claims 1
- 102220540610 UbiA prenyltransferase domain-containing protein 1_D118G_mutation Human genes 0.000 claims 1
- 102220540431 UbiA prenyltransferase domain-containing protein 1_D240N_mutation Human genes 0.000 claims 1
- 102220540626 UbiA prenyltransferase domain-containing protein 1_G98S_mutation Human genes 0.000 claims 1
- 102220540606 UbiA prenyltransferase domain-containing protein 1_L121F_mutation Human genes 0.000 claims 1
- 102220540600 UbiA prenyltransferase domain-containing protein 1_L188H_mutation Human genes 0.000 claims 1
- 102220540595 UbiA prenyltransferase domain-containing protein 1_V122E_mutation Human genes 0.000 claims 1
- 102220540602 UbiA prenyltransferase domain-containing protein 1_V122G_mutation Human genes 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 210000003527 eukaryotic cell Anatomy 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 102200059610 rs118203945 Human genes 0.000 claims 1
- 102200059669 rs118203946 Human genes 0.000 claims 1
- 102200059615 rs118203947 Human genes 0.000 claims 1
- 102200059663 rs118203948 Human genes 0.000 claims 1
- 102200059672 rs118203949 Human genes 0.000 claims 1
- 102200059611 rs118203950 Human genes 0.000 claims 1
- 102200059492 rs118203951 Human genes 0.000 claims 1
- 102200059666 rs118203952 Human genes 0.000 claims 1
- 102200059673 rs118203953 Human genes 0.000 claims 1
- 102220086650 rs142371511 Human genes 0.000 claims 1
- 102200081932 rs2274064 Human genes 0.000 claims 1
- 102200004717 rs267607386 Human genes 0.000 claims 1
- 102200004568 rs267607387 Human genes 0.000 claims 1
- 102220024596 rs267607431 Human genes 0.000 claims 1
- 102200004567 rs28936695 Human genes 0.000 claims 1
- 102200004548 rs57218384 Human genes 0.000 claims 1
- 102200004597 rs57218384 Human genes 0.000 claims 1
- 102200053908 rs57872071 Human genes 0.000 claims 1
- 102200004598 rs58038639 Human genes 0.000 claims 1
- 102200004576 rs58162394 Human genes 0.000 claims 1
- 102200004553 rs58410481 Human genes 0.000 claims 1
- 102200004569 rs58864803 Human genes 0.000 claims 1
- 102200004601 rs58918655 Human genes 0.000 claims 1
- 102200004582 rs59202432 Human genes 0.000 claims 1
- 102200004607 rs59350319 Human genes 0.000 claims 1
- 102220024224 rs59465138 Human genes 0.000 claims 1
- 102200053910 rs60410063 Human genes 0.000 claims 1
- 102220024225 rs61167390 Human genes 0.000 claims 1
- 102200004596 rs61282718 Human genes 0.000 claims 1
- 102200004578 rs62635290 Human genes 0.000 claims 1
- 102220118475 rs781152868 Human genes 0.000 claims 1
- 102200004551 rs886038212 Human genes 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021214009A JP2022046694A (ja) | 2016-08-20 | 2021-12-28 | 一本鎖ガイドＲＮＡ、ＣＲＩＳＰＲ／Ｃａｓ９システム、及びそれらの使用方法 |
| JP2024002942A JP2024041905A (ja) | 2016-08-20 | 2024-01-12 | 一本鎖ガイドＲＮＡ、ＣＲＩＳＰＲ／Ｃａｓ９システム、及びそれらの使用方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662377586P | 2016-08-20 | 2016-08-20 | |
| US62/377,586 | 2016-08-20 | ||
| US201762462808P | 2017-02-23 | 2017-02-23 | |
| US62/462,808 | 2017-02-23 | ||
| US201762501750P | 2017-05-05 | 2017-05-05 | |
| US62/501,750 | 2017-05-05 | ||
| PCT/US2017/047861 WO2018039145A1 (en) | 2016-08-20 | 2017-08-21 | Single guide rna, crispr/cas9 systems, and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021214009A Division JP2022046694A (ja) | 2016-08-20 | 2021-12-28 | 一本鎖ガイドＲＮＡ、ＣＲＩＳＰＲ／Ｃａｓ９システム、及びそれらの使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019524149A JP2019524149A (ja) | 2019-09-05 |
| JP2019524149A5 true JP2019524149A5 (enExample) | 2020-10-01 |
Family
ID=61246315
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019510339A Pending JP2019524149A (ja) | 2016-08-20 | 2017-08-21 | 一本鎖ガイドＲＮＡ、ＣＲＩＳＰＲ／Ｃａｓ９システム、及びそれらの使用方法 |
| JP2021214009A Pending JP2022046694A (ja) | 2016-08-20 | 2021-12-28 | 一本鎖ガイドＲＮＡ、ＣＲＩＳＰＲ／Ｃａｓ９システム、及びそれらの使用方法 |
| JP2024002942A Pending JP2024041905A (ja) | 2016-08-20 | 2024-01-12 | 一本鎖ガイドＲＮＡ、ＣＲＩＳＰＲ／Ｃａｓ９システム、及びそれらの使用方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021214009A Pending JP2022046694A (ja) | 2016-08-20 | 2021-12-28 | 一本鎖ガイドＲＮＡ、ＣＲＩＳＰＲ／Ｃａｓ９システム、及びそれらの使用方法 |
| JP2024002942A Pending JP2024041905A (ja) | 2016-08-20 | 2024-01-12 | 一本鎖ガイドＲＮＡ、ＣＲＩＳＰＲ／Ｃａｓ９システム、及びそれらの使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20190185850A1 (enExample) |
| EP (1) | EP3500677A4 (enExample) |
| JP (3) | JP2019524149A (enExample) |
| KR (2) | KR20230155013A (enExample) |
| CN (1) | CN109963945A (enExample) |
| WO (1) | WO2018039145A1 (enExample) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2853829C (en) | 2011-07-22 | 2023-09-26 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
| US9828582B2 (en) | 2013-03-19 | 2017-11-28 | Duke University | Compositions and methods for the induction and tuning of gene expression |
| US9163284B2 (en) | 2013-08-09 | 2015-10-20 | President And Fellows Of Harvard College | Methods for identifying a target site of a Cas9 nuclease |
| US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
| US9322037B2 (en) | 2013-09-06 | 2016-04-26 | President And Fellows Of Harvard College | Cas9-FokI fusion proteins and uses thereof |
| US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| US9340800B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | Extended DNA-sensing GRNAS |
| US9840699B2 (en) | 2013-12-12 | 2017-12-12 | President And Fellows Of Harvard College | Methods for nucleic acid editing |
| WO2016022363A2 (en) | 2014-07-30 | 2016-02-11 | President And Fellows Of Harvard College | Cas9 proteins including ligand-dependent inteins |
| WO2016130600A2 (en) | 2015-02-09 | 2016-08-18 | Duke University | Compositions and methods for epigenome editing |
| IL294014B2 (en) | 2015-10-23 | 2024-07-01 | Harvard College | Nucleobase editors and uses thereof |
| EP3374502B1 (en) | 2015-11-13 | 2021-10-27 | Avellino Lab USA, Inc. | Methods for the treatment of corneal dystrophies |
| CN108779466B (zh) | 2015-11-30 | 2024-03-29 | 杜克大学 | 用于通过基因编辑修正人肌营养不良蛋白基因的治疗靶标和使用方法 |
| WO2017180915A2 (en) | 2016-04-13 | 2017-10-19 | Duke University | Crispr/cas9-based repressors for silencing gene targets in vivo and methods of use |
| WO2018017754A1 (en) | 2016-07-19 | 2018-01-25 | Duke University | Therapeutic applications of cpf1-based genome editing |
| AU2017306676B2 (en) | 2016-08-03 | 2024-02-22 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
| EP3497214B1 (en) | 2016-08-09 | 2023-06-28 | President and Fellows of Harvard College | Programmable cas9-recombinase fusion proteins and uses thereof |
| WO2020225754A1 (en) * | 2019-05-06 | 2020-11-12 | Mcmullen Tara | Crispr gene editing for autosomal dominant diseases |
| WO2019165322A1 (en) * | 2018-02-22 | 2019-08-29 | Moore Tara | Crispr/cas9 systems, and methods of use thereof |
| EP3500677A4 (en) * | 2016-08-20 | 2020-04-01 | Avellino Lab USA, Inc. | Single guide rna, crispr/cas9 systems, and methods of use thereof |
| WO2020046861A1 (en) * | 2018-08-27 | 2020-03-05 | Avellino Lab Usa, Inc. | Crispr/cas9 systems, and methods of use thereof |
| US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| WO2018071868A1 (en) | 2016-10-14 | 2018-04-19 | President And Fellows Of Harvard College | Aav delivery of nucleobase editors |
| WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
| EP3592853A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Suppression of pain by gene editing |
| WO2018165631A1 (en) | 2017-03-09 | 2018-09-13 | President And Fellows Of Harvard College | Cancer vaccine |
| WO2018165629A1 (en) | 2017-03-10 | 2018-09-13 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
| KR20240116572A (ko) | 2017-03-23 | 2024-07-29 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제 |
| US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
| JP7161730B2 (ja) * | 2017-06-07 | 2022-10-27 | 国立大学法人 東京大学 | 顆粒状角膜変性症に対する遺伝子治療薬 |
| CN111801345A (zh) | 2017-07-28 | 2020-10-20 | 哈佛大学的校长及成员们 | 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物 |
| US11319532B2 (en) | 2017-08-30 | 2022-05-03 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
| WO2019079347A1 (en) | 2017-10-16 | 2019-04-25 | The Broad Institute, Inc. | USES OF BASIC EDITORS ADENOSINE |
| US12406749B2 (en) | 2017-12-15 | 2025-09-02 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| US12509492B2 (en) | 2018-01-19 | 2025-12-30 | Duke University | Genome engineering with CRISPR-Cas systems in eukaryotes |
| JP7550648B2 (ja) * | 2018-03-19 | 2024-09-13 | クリスパー セラピューティクス アーゲー | 新規ｒｎａプログラム可能エンドヌクレアーゼ系およびその使用 |
| EP3790961A1 (en) * | 2018-05-08 | 2021-03-17 | Katholieke Universiteit Leuven | Biosensor |
| EP3797160A1 (en) | 2018-05-23 | 2021-03-31 | The Broad Institute Inc. | Base editors and uses thereof |
| WO2020014261A1 (en) | 2018-07-09 | 2020-01-16 | The Broad Institute, Inc. | Rna programmable epigenetic rna modifiers and uses thereof |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| CN113710799B (zh) | 2018-11-28 | 2024-11-12 | 克里斯珀医疗股份公司 | 用于在LNP中使用的编码CAS9的优化mRNA |
| WO2020154500A1 (en) | 2019-01-23 | 2020-07-30 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| BR112021018607A2 (pt) | 2019-03-19 | 2021-11-23 | Massachusetts Inst Technology | Métodos e composições para editar sequências de nucleotídeos |
| EP3956349A1 (en) | 2019-04-17 | 2022-02-23 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| CN110499335B (zh) * | 2019-08-08 | 2023-03-28 | 复旦大学 | CRISPR/SauriCas9基因编辑系统及其应用 |
| CN110551763B (zh) * | 2019-08-08 | 2023-03-10 | 复旦大学 | CRISPR/SlutCas9基因编辑系统及其应用 |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| JP2023505737A (ja) * | 2019-12-11 | 2023-02-10 | アベリノ ラボ ユーエスエー インコーポレイテッド | Ｒ１２４ｈ突然変異を備えたトランスフォーミング増殖因子ベータ誘導遺伝子の短鎖干渉ｒｎａを使用したアレル特異的サイレンシング |
| AU2021267940A1 (en) | 2020-05-08 | 2022-12-08 | President And Fellows Of Harvard College | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
| CN111926015B (zh) * | 2020-08-24 | 2022-07-15 | 武汉纽福斯生物科技有限公司 | 寡核苷酸、病毒载体及其应用和RNAi药物制剂 |
| AU2022216614A1 (en) * | 2021-02-05 | 2023-02-23 | Christiana Care Gene Editing Institute, Inc. | Methods of and compositions for reducing gene expression and/or activity |
| WO2023034704A1 (en) * | 2021-08-31 | 2023-03-09 | The Regents Of The University Of California | Products and methods for annotating gene function using locally haploid, human non-cancer cells |
| EP4469577A2 (en) * | 2022-01-26 | 2024-12-04 | Orthobio Therapeutics, Inc. | Gene editing to improve joint function |
| US20250235559A1 (en) * | 2022-02-25 | 2025-07-24 | Incisive Genetics Inc. | Gene editing reporter system and guide rna and composition related thereto; composition and method for knocking out dna with more than two grnas; gene editing in the eye; and gene editing using base editors |
| CN115948537B (zh) * | 2022-12-19 | 2024-04-09 | 湖南家辉生物技术有限公司 | 一种基因chst3复合杂合突变的应用及检测试剂和应用 |
| CN116286823A (zh) * | 2023-04-04 | 2023-06-23 | 尧唐(上海)生物科技有限公司 | 靶向TGFBI基因的sgRNA、载体及其应用 |
| WO2025043140A1 (en) * | 2023-08-23 | 2025-02-27 | Emendobio Inc. | Methods and compositions for modifying expression of a mutant transforming growth factor beta induced (tgfbi) allele |
| CN119464347B (zh) * | 2024-11-26 | 2025-10-03 | 扬州大学 | 基于CRISPR-Cas9系统的噬菌体基因组编辑载体及其编辑方法和应用 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5049386A (en) | 1985-01-07 | 1991-09-17 | Syntex (U.S.A.) Inc. | N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US4946787A (en) | 1985-01-07 | 1990-08-07 | Syntex (U.S.A.) Inc. | N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US9895451B2 (en) | 2011-12-02 | 2018-02-20 | Yale University | Formulations for targeted release of agents to low pH tissue environments or cellular compartments and methods of use thereof |
| US10266850B2 (en) * | 2012-05-25 | 2019-04-23 | The Regents Of The University Of California | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription |
| CN104704110B (zh) | 2012-08-29 | 2018-06-01 | 桑格摩生物科学股份有限公司 | 用于治疗遗传性病状的方法和组合物 |
| CA3034794A1 (en) * | 2012-12-06 | 2014-06-12 | Sigma-Aldrich Co. Llc | Crispr-based genome modification and regulation |
| RU2721275C2 (ru) | 2012-12-12 | 2020-05-18 | Те Брод Инститьют, Инк. | Доставка, конструирование и оптимизация систем, способов и композиций для манипуляции с последовательностями и применения в терапии |
| WO2014093694A1 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes |
| WO2014093655A2 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains |
| CN105121648B (zh) | 2012-12-12 | 2021-05-07 | 布罗德研究所有限公司 | 用于序列操纵的系统、方法和优化的指导组合物的工程化 |
| WO2014093701A1 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| EP4234696A3 (en) | 2012-12-12 | 2023-09-06 | The Broad Institute Inc. | Crispr-cas component systems, methods and compositions for sequence manipulation |
| AU2013359212B2 (en) | 2012-12-12 | 2017-01-19 | Massachusetts Institute Of Technology | Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation |
| EP2940140B1 (en) | 2012-12-12 | 2019-03-27 | The Broad Institute, Inc. | Engineering of systems, methods and optimized guide compositions for sequence manipulation |
| JP6414945B2 (ja) * | 2013-03-11 | 2018-10-31 | Ｊｃｒファーマ株式会社 | ヒト角膜上皮シートの製造法 |
| JP2016521975A (ja) | 2013-05-15 | 2016-07-28 | サンガモ バイオサイエンシーズ， インコーポレイテッド | 遺伝的状態の処置のための方法および組成物 |
| EP3011029B1 (en) * | 2013-06-17 | 2019-12-11 | The Broad Institute, Inc. | Delivery, engineering and optimization of tandem guide systems, methods and compositions for sequence manipulation |
| KR20220025922A (ko) * | 2013-07-09 | 2022-03-03 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 멀티플렉스 rna-가이드된 게놈 조작 |
| WO2015021426A1 (en) * | 2013-08-09 | 2015-02-12 | Sage Labs, Inc. | A crispr/cas system-based novel fusion protein and its application in genome editing |
| US10787684B2 (en) * | 2013-11-19 | 2020-09-29 | President And Fellows Of Harvard College | Large gene excision and insertion |
| WO2016049024A2 (en) | 2014-09-24 | 2016-03-31 | The Broad Institute Inc. | Delivery, use and therapeutic applications of the crispr-cas systems and compositions for modeling competition of multiple cancer mutations in vivo |
| WO2017062983A1 (en) * | 2015-10-09 | 2017-04-13 | The Children's Hospital Of Philadelphia | Compositions and methods for treating huntington's disease and related disorders |
| EP3374502B1 (en) * | 2015-11-13 | 2021-10-27 | Avellino Lab USA, Inc. | Methods for the treatment of corneal dystrophies |
| EP3500677A4 (en) * | 2016-08-20 | 2020-04-01 | Avellino Lab USA, Inc. | Single guide rna, crispr/cas9 systems, and methods of use thereof |
-
2017
- 2017-08-21 EP EP17844228.1A patent/EP3500677A4/en not_active Withdrawn
- 2017-08-21 US US16/326,908 patent/US20190185850A1/en not_active Abandoned
- 2017-08-21 KR KR1020237036111A patent/KR20230155013A/ko not_active Ceased
- 2017-08-21 CN CN201780064151.5A patent/CN109963945A/zh active Pending
- 2017-08-21 WO PCT/US2017/047861 patent/WO2018039145A1/en not_active Ceased
- 2017-08-21 KR KR1020197007806A patent/KR102594051B1/ko active Active
- 2017-08-21 JP JP2019510339A patent/JP2019524149A/ja active Pending
-
2021
- 2021-12-28 JP JP2021214009A patent/JP2022046694A/ja active Pending
-
2024
- 2024-01-12 JP JP2024002942A patent/JP2024041905A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019524149A5 (enExample) | ||
| US20230407341A1 (en) | Using Truncated Guide RNAs (tru-gRNAs) to Increase Specificity for RNA-Guided Genome Editing | |
| JP7379447B2 (ja) | ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子 | |
| CN107787367B (zh) | 用于crispr/cas介导的基因调控的化学修饰的引导rna | |
| CN108350454B (zh) | 等位基因选择性基因编辑及其用途 | |
| JP2023113627A (ja) | シトシンからグアニンへの塩基編集因子 | |
| JP2016537028A5 (enExample) | ||
| WO2015115903A1 (en) | Site-specific dna break-induced genome editing using engineered nucleases | |
| FI3802807T3 (fi) | Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja menetelmiä niiden käyttämiseksi | |
| JP2019522461A5 (enExample) | ||
| JP2019115348A5 (enExample) | ||
| JP2018518182A5 (enExample) | ||
| KR20190090848A (ko) | 변형된 가이드 rna | |
| JP2018534950A5 (enExample) | ||
| IL302205B2 (en) | Rna-guided transcriptional regulation | |
| JP2016501532A5 (enExample) | ||
| JP2022023144A5 (enExample) | ||
| RU2020100919A (ru) | СПОСОБ НОКАУТИРОВАНИЯ ГЕНА-МИШЕНИ В T-КЛЕТКЕ IN VITRO И crRNA, ПРИМЕНЯЕМАЯ В ДАННОМ СПОСОБЕ | |
| ES2285118T5 (es) | Un método para el desarrollo molecular in vitro de una función proteica. | |
| WO2023220742A3 (en) | Abca4 trans-splicing molecules | |
| Chen et al. | Mitochondria isolated from liver contain the essential factors required for RNA/DNA oligonucleotide-targeted gene repair | |
| Eslahi et al. | New advancements in CRISPR based gene therapy of Duchenne muscular dystrophy | |
| JPWO2020223514A5 (enExample) | ||
| WO2024173573A1 (en) | Crispr-transposon systems and components | |
| JPWO2021152146A5 (enExample) |